PT Siloam International Hospitals Tbk
IDX:SILO.JK
3140 (IDR) • At close October 30, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) IDR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 11,190,511 | 9,518,012 | 9,381,891 | 7,110,124 | 7,017,919 | 5,964,650 | 5,848,006 | 5,168,363.067 | 4,144,118.303 | 3,340,793.372 | 2,503,599.993 | 1,788,082.522 | 1,259,348.566 | 1,030,471.74 |
| Cost of Revenue
| 7,545,606 | 5,984,623 | 5,764,949 | 4,779,194 | 4,818,022 | 4,035,795 | 4,196,881 | 3,646,195.117 | 2,967,571.739 | 2,388,731.054 | 1,844,902.052 | 1,343,268.006 | 925,764.461 | 772,920.713 |
| Gross Profit
| 3,644,905 | 3,533,389 | 3,616,942 | 2,330,930 | 2,199,897 | 1,928,855 | 1,651,125 | 1,522,167.95 | 1,176,546.563 | 952,062.318 | 658,697.941 | 444,814.516 | 333,584.104 | 257,551.027 |
| Gross Profit Ratio
| 0.326 | 0.371 | 0.386 | 0.328 | 0.313 | 0.323 | 0.282 | 0.295 | 0.284 | 0.285 | 0.263 | 0.249 | 0.265 | 0.25 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 707,063 | 629,160 | 684,519 | 440,775 | 618,942 | 541,708 | 442,385 | 430,620.295 | 351,950.378 | 318,686.78 | 240,008.977 | 140,135.265 | 78,388.006 | 58,749.948 |
| Selling & Marketing Expenses
| 120,319 | 87,729 | 62,865 | 14,180 | 51,625 | 49,070 | 52,055 | 44,759.688 | 21,377.484 | 16,843.188 | 16,111.002 | 8,860.827 | 3,726.529 | 2,369.65 |
| SG&A
| 1,847,703 | 716,889 | 747,384 | 454,955 | 670,567 | 590,778 | 494,440 | 475,379.983 | 373,327.862 | 335,529.968 | 256,119.979 | 148,996.092 | 82,114.535 | 61,119.599 |
| Other Expenses
| -52,157 | 1,667,330 | 1,699,769 | 1,332,769 | 1,411,131 | -106,864 | -77,703 | -69,915.259 | -53,156.677 | -34,262.796 | 323,893.165 | 14,516.64 | -17,358.728 | 3,255.965 |
| Operating Expenses
| 1,899,860 | 2,384,219 | 2,447,153 | 1,787,724 | 2,081,698 | 1,630,339 | 1,354,134 | 1,230,554.558 | 965,324.197 | 783,947.104 | 580,013.144 | 367,863.019 | 245,056.198 | 156,897.788 |
| Operating Income
| 1,745,045 | 1,022,332 | 1,018,703 | 390,592 | 38,476 | 191,652 | 219,288 | 221,698.133 | 158,065.689 | 133,852.418 | 78,684.797 | 91,468.137 | 71,169.178 | 103,909.205 |
| Operating Income Ratio
| 0.156 | 0.107 | 0.109 | 0.055 | 0.005 | 0.032 | 0.037 | 0.043 | 0.038 | 0.04 | 0.031 | 0.051 | 0.057 | 0.101 |
| Total Other Income Expenses Net
| -78,636 | -38,025 | -45,838 | -79,942 | -188,012 | -132,360 | -96,952 | -119,319.583 | -105,475.747 | -74,609.276 | -6,923.649 | 70.084 | -30,787.238 | -7,084.324 |
| Income Before Tax
| 1,666,409 | 984,307 | 972,865 | 310,650 | -149,536 | 166,156 | 200,039 | 172,293.809 | 105,746.619 | 93,505.937 | 71,761.148 | 77,021.581 | 57,740.668 | 93,568.915 |
| Income Before Tax Ratio
| 0.149 | 0.103 | 0.104 | 0.044 | -0.021 | 0.028 | 0.034 | 0.033 | 0.026 | 0.028 | 0.029 | 0.043 | 0.046 | 0.091 |
| Income Tax Expense
| 419,365 | 273,926 | 272,681 | 185,400 | 183,462 | 139,763 | 96,518 | 73,591.844 | 44,040.543 | 33,799.164 | 21,568.661 | 25,061.979 | 19,860.698 | 21,695.432 |
| Net Income
| 1,211,283 | 696,495 | 674,117 | 116,163 | -332,998 | 16,182 | 93,566 | 85,900.715 | 70,396.404 | 62,568.929 | 49,870.419 | 50,461.222 | 43,740.346 | 67,476.614 |
| Net Income Ratio
| 0.108 | 0.073 | 0.072 | 0.016 | -0.047 | 0.003 | 0.016 | 0.017 | 0.017 | 0.019 | 0.02 | 0.028 | 0.035 | 0.065 |
| EPS
| 93.27 | 70.74 | 52.12 | 8.94 | -25.6 | 1.24 | 8.54 | 9.06 | 7.47 | 7.6 | 5.82 | 6.17 | 5.35 | 17.52 |
| EPS Diluted
| 92.92 | 70.59 | 52.02 | 8.94 | -25.6 | 1.24 | 8.54 | 9.06 | 7.47 | 7.6 | 5.82 | 6.17 | 5.35 | 17.52 |
| EBITDA
| 2,687,340 | 1,856,320 | 1,861,014 | 890,463 | 311,582 | 396,170 | 358,737 | 308,460.62 | 247,646.584 | 211,734.355 | 131,162.805 | 126,968.441 | 96,008.439 | 109,855.024 |
| EBITDA Ratio
| 0.24 | 0.195 | 0.198 | 0.125 | 0.044 | 0.066 | 0.061 | 0.06 | 0.06 | 0.063 | 0.052 | 0.071 | 0.076 | 0.107 |